Tech Company Financing Transactions
DexCare Funding Round
DexCare secured a $50 million Series B financing round on 1/20/2022. Investors included Transformation Capital, Define Ventures and Frist Cressey Venture.
Transaction Overview
Company Name
Announced On
1/20/2022
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series B
Investors
Proceeds Purpose
The new funds will be used to support and accelerate DexCare's growth with investments in product and technology innovation, customer experience, and recruiting.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
Undisclosed
Seattle, WA 98101
USA
Seattle, WA 98101
USA
Phone
Undisclosed
Website
Email Address
Overview
DexCare is a Seattle-based healthcare technology company on a mission to empower those that provide care with the tools, systems and intelligence necessary to deliver on this vision. DexCare was born out of Providence, one of the largest and most digitally forward health systems in the US.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Derek Streat
Chief Marketing Officer
Aaron Martin
Founder
Sean O'Connor
Founder
Lynne O'Keefe
Browse more venture capital transactions:
Prev: 1/20/2022: Twig venture capital transaction
Next: 1/20/2022: Fertilis venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC transactions reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs